Vesna Ćeriman Krstić

8PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 28, 2026
PD-L1 and BAP1 as Prognostic Biomarkers in Malignant Pleural Mesothelioma.

Milija Gajić, Vesna Ćeriman Krstić, Natalija Samardžić

|Sep 27, 2025
Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.

Vesna Ćeriman Krstić, Natalija Samardžić, Mihailo Stjepanović

|Apr 25, 2025
Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression.

Vesna Ćeriman Krstić, Ivan Soldatović, Milija Gajić

|Jan 24, 2025
The Potential Role of sPD-L1 as a Predictive Biomarker in EGFR-Positive Non-Small-Cell Lung Cancer.

Vesna Ćeriman Krstić, Dragana Jovanović, Natalija Samardžić

|Dec 27, 2024
Treatment Options for Patients with Non-Small Cell Lung Cancer and Liver Metastases.

Vesna Ćeriman Krstić, Natalija Samardžić, Milija Gajić

Pageof 2